Cargando…

Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?

SIMPLE SUMMARY: Immune checkpoint blockade (ICB) has emerged as a very promising therapeutic option for patients, demonstrating unprecedented, durable responses in several difficult-to-treat cancers. Despite research indicating a strong potential for ICB in uterine leiomyosarcomas (uLMSs), a clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Wispelaere, Wout, Annibali, Daniela, Tuyaerts, Sandra, Lambrechts, Diether, Amant, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122870/ https://www.ncbi.nlm.nih.gov/pubmed/33922556 http://dx.doi.org/10.3390/cancers13092040

Ejemplares similares

The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma
por: Maia Falcão, Raul, et al.
Publicado: (2022)

Potential Therapeutic Targets in Uterine Sarcomas
por: Cuppens, Tine, et al.
Publicado: (2015)

Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
por: Baiden-Amissah, Regina Esi Mensimah, et al.
Publicado: (2021)

Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin
por: Amant, Frédéric, et al.
Publicado: (2015)

Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy
por: Vanderstraeten, Anke, et al.
Publicado: (2014)

Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions
por: Żak, Klaudia, et al.
Publicado: (2022)

Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022)

Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy
por: Tuyaerts, Sandra, et al.
Publicado: (2018)

PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer
por: Tuyaerts, Sandra, et al.
Publicado: (2019)

The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies
por: Marinelli, Oliviero, et al.
Publicado: (2019)

In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer
por: Vanderstraeten, Anke, et al.
Publicado: (2016)

Microvessels Density in Uterine Leiomyosarcoma
por: Bobiński, Marcin, et al.
Publicado: (2015)

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma
por: Lamm, Wolfgang, et al.
Publicado: (2014)

Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2011)

The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer
por: Marinelli, Oliviero, et al.
Publicado: (2020)

Biological Function of PD-L2 and Correlation With Overall Survival in Type II Endometrial Cancer
por: Marinelli, Oliviero, et al.
Publicado: (2020)

Potential Biomarker for Human Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2014)

Uterine leiomyosarcoma: A case report
por: Kaur, Khushpreet, et al.
Publicado: (2014)

Prevalence and occult rates of uterine leiomyosarcoma
por: Wang, Lingxiang, et al.
Publicado: (2020)

A Case Report Of Uterine Leiomyosarcoma
por: Cao, Siyu, et al.
Publicado: (2019)

The Role of Hedgehog Pathway in Uterine Leiomyosarcoma
por: Garcia, Natalia, et al.
Publicado: (2021)

Perforated intestinal leiomyosarcoma as a metastasis of uterine leiomyosarcoma: a case report
por: Saylam, Barış, et al.
Publicado: (2009)

Cervical leiomyosarcoma in a teenage girl: A rare form of uterine leiomyosarcoma()
por: Adewole, Adebayo A., et al.
Publicado: (2021)

Vulvar Leiomyosarcomas: A Case Series with Clinical Comparison to Uterine Leiomyosarcomas and Review of the Literature
por: Verta, Stephanie, et al.
Publicado: (2023)

Uterine leiomyosarcoma with central nervous system metastases
por: Abrahão, Carina Meira, et al.
Publicado: (2015)

Rare Endobronchial metastasis from uterine leiomyosarcoma
por: Ghosh, Saswata, et al.
Publicado: (2015)

A Case of Renal Metastasis of Uterine Leiomyosarcoma
por: Bajic, Petar, et al.
Publicado: (2017)

Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells
por: de Almeida, Bruna Cristine, et al.
Publicado: (2017)

Targeting homologous recombination deficiency in uterine leiomyosarcoma
por: Dall, Genevieve, et al.
Publicado: (2023)

A Rare Case of Uterine Myxoid Leiomyosarcoma
por: Wankhade, Rashmi, et al.
Publicado: (2023)

Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?
por: Wessely, Anja, et al.
Publicado: (2020)

The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers
por: Moens, Stijn, et al.
Publicado: (2021)

A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer
por: Tuyaerts, Sandra, et al.
Publicado: (2019)

Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN
por: Guo, Xi, et al.
Publicado: (2022)

Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma
por: Zhou, Maggie, et al.
Publicado: (2022)

Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers
por: Van Nyen, Tom, et al.
Publicado: (2022)

Uterine Leiomyosarcoma Manifesting as a Tricuspid Valve Mass
por: Marak, Creticus P., et al.
Publicado: (2013)

Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
por: Thanopoulou, Eirini, et al.
Publicado: (2014)

Current Chemotherapy and Potential New Targets in Uterine Leiomyosarcoma
por: Momtahen, Shabnam, et al.
Publicado: (2016)

Molecular Subtypes of Uterine Leiomyosarcoma and Correlation with Clinical Outcome()()
por: Barlin, Joyce N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ln1k1tn39krd680c3986ag5ek9